Source: https://patents.google.com/patent/US8771229B2/en
Timestamp: 2018-11-14 09:15:17
Document Index: 89723706

Matched Legal Cases: ['art 201', 'art 201', 'art 201', 'art 702', 'art 702', 'art 201', 'art 702']

US8771229B2 - Cartridge system for delivery of medicament - Google Patents
Cartridge system for delivery of medicament Download PDF
US8771229B2
US8771229B2 US13308899 US201113308899A US8771229B2 US 8771229 B2 US8771229 B2 US 8771229B2 US 13308899 US13308899 US 13308899 US 201113308899 A US201113308899 A US 201113308899A US 8771229 B2 US8771229 B2 US 8771229B2
US13308899
US20130144214A1 (en )
A cartridge system for delivery of medicament includes as membrane placed between two disk magnets that are housed within pump body inserts. The pump body inserts having flow channels and fluid openings are between two inlet/outlet members. The inlet/outlet members each having a fluid outlet component and fluid openings are securely engaged to two reservoirs containing fluid medicaments.
The present invention relates to the field of medical devices and, in particular, to devices for delivery of medicament. More particularly, the present invention relates to a cartridge system for delivery of insulin or other medicament.
Diabetes may be controlled by insulin replacement therapy in which insulin is delivered to the diabetic person, usually by injection, to counteract elevated blood glucose levels. Recent therapies include the basal/bolus method of treatment in which basal, a long acting insulin medication, for example, Humalog® and Apidra®, is delivered via injection once every day. The basal provides the body with a relatively constant dose of insulin throughout the day. At mealtime, an additional dose of insulin, or bolus, is administered based on the amount of carbohydrate and protein in the meal. Accurate calculations of various parameters including the amount of carbohydrates and proteins consumed, and the lapse in time since the last dosage are necessary to determine the appropriate dosage of insulin. The dosages are thus prone to human error and the method is ineffective when doses are skipped, forgotten or miscalculated. Exercise, stress and other factors can also cause the calculations to be inaccurate.
To address these problems, programmable insulin delivery devices or pumps were developed which seek to mimic the way a normal, healthy pancreas delivers insulin to the body. Insulin pumps are programmed to deliver a continual basal dose of insulin and occasionally a bolus dose in response to a patient's meal intake and physical activities. Additionally, the number of times a patient is required to draw blood and test their glucose during the day is reduced, thus lessening the pain and inconvenience of this disease.
Conventional insulin pumps are worn on the body and are connected to a patient via a cannula that is inserted somewhere on the patient's abdomen. The insulin is delivered under the skin and is absorbed into the body through the subcutaneous fat layer. Insulin pumps in the past have been quite large, some requiring the use of a shoulder bag to transport. Over time, they have become smaller in size and most pumps today are roughly the size of a deck of cards. Currently available insulin pumps include Animas OneTouch® Ping®, Deltec Cozmo®, Disetronic Accu-Chek Spirit®, Insulet OmniPod, Medtronic Paradigm™, Sooil USA Diabecarell, and Nipro Amigo®.
With the decreased size of the pump unit also comes a decreased size in the medication reservoir. This reduced reservoir size means more frequent refilling, greater potential for contamination of the reservoir, more frequent changes of the cannula and tubing, and greater expense overall in treating the condition. Recent medical data suggests that a combination of insulin and another medication, such as glucagon, infused at different times or simultaneously, leads to better results in patients.
Therefore, the need exists for a low-cost cartridge system, capable of working in tandem with a pump driver system, that contains a plurality of reservoirs for the delivery of more than one drug.
The present invention overcomes the disadvantages of the prior art and fulfills the needs noted above by providing a drug delivery device having a pump driver system, and a cartridge system.
More specifically, the present invention includes a cartridge system having a plurality of reservoirs each with volume, preferably, of 1.5 ml. Each of the plurality of reservoirs can be pre-filled with different medicaments. A pump membrane is placed between two gold-plated neodymium-iron-boron disk magnets that are each housed within a pump body insert. Each of the pump body inserts has a fluid receiving opening, a fluid discharge opening, a plurality of inlet channels, and a plurality of outlet channels. The pump body inserts are placed between two inlet/outlet members. Each of the inlet/outlet members has a fluid receiving opening, a fluid discharge opening, and a fluid outlet component. Additionally, each of the inlet/outlet members has a male part that securely engages to a female part of the reservoir forming an airtight seal. The reservoir, the fluid receiving opening of the inlet/outlet member, the fluid receiving opening, the plurality of inlet channels, the plurality of outlet channels, and the fluid discharge opening of the pump body insert, the fluid discharge opening and the fluid outlet component of the inlet/outlet member are in fluid communication. The cartridge system further includes valve membranes that are placed between the fluid receiving openings of the pump body inserts and the inlet/outlet members, and between the fluid discharge openings of the pump body inserts and the inlet/outlet members.
The valve membranes of the cartridge system can be pre-stressed and formed, for example, of Silastic Q7-4840. The reservoirs can be formed, for example, of Silastic Q7-4840, or Medical Grade Polyisoprene. The pump body inserts and the inlet/outlet members can be formed, for example, of clear polypropylene homopolymer. The pump membrane can be formed, for example, of Silastic Q7-4840.
The present invention also includes a cartridge system having a plurality of orifices to fill or re-fill a plurality of medicaments in the reservoirs. The plurality of orifices can be located on the reservoirs, or on the inlet/outlet members and the plurality of orifices are in fluid communication with the reservoirs.
The present invention further includes a method of delivering medicament using a drug delivery device having a cartridge system. The method includes the steps of providing a drug delivery device having a pump driver system and a cartridge system, loading a plurality of pre-filled reservoirs containing fluid medicament to the cartridge system, engaging securely the cartridge system and the pump driver system, selecting various parameters on a user interface of the pump driver system including selecting pre-determined values or specifying user-defined values for the parameters, and connecting an infusion set to the drug delivery device.
The present invention also includes a method of delivering medicament using the drug delivery device having the cartridge system. The method includes the steps of providing a drug delivery device having a pump driver system and a cartridge system, loading a plurality of reservoirs to the cartridge system, using an instrument to inject a plurality of fluid medicaments into the plurality of reservoirs, engaging securely the cartridge system and the pump driver system, selecting various parameters on a user interface of the pump driver system including selecting pre-determined values or specifying user-defined values for the parameters, and connecting an infusion set to the drug delivery device. The step of connecting an infusion set to the drug delivery device further includes the steps of connecting one end of a Y-catheter to an outlet component of an inlet/outlet member, and delivering fluid medicament at a given rate. The step of delivering fluid medicament at a given rate can further include delivering fluid medicament at a controlled and continuous rate for a pre-determined or user-defined period of time. Alternatively, the step of delivering fluid medicament at a given rate can further include delivering fluid medicament at a programmable rate that is regulated by the patient.
The present invention further includes a drug delivery device having a pump driver system, a cartridge system, a cannula and an insertion mechanism, and a plurality of conduits. The pump driver system includes a driver that drives the magnets that applies a force to the pump membrane of the cartridge system, a controller in communication with the pump to adjust the force applied by the driver, a power source, and a user interface configured to present information to a user. The cartridge system of the device snaps into the pump driver system and is securely engaged to it. The plurality of conduits each includes a proximal end, a distal end, and a lumen extending from its proximal end to its distal end. The proximal ends of the plurality of conduits are securely engaged to the distal ends of the cannula and the insertion mechanism, and the distal ends are securely engaged to the proximal ends of the fluid outlet component of the inlet/outlet members of the cartridge system.
FIGS. 1A-1C illustrate a perspective view, rear elevation and top view, respectively, of a cartridge system in accordance with an embodiment of the present invention;
FIGS. 2A-2C illustrate a perspective view, front view and top view, respectively, of a reservoir of the cartridge system in accordance with an embodiment of the present invention;
FIG. 2D illustrates a sectional view of a reservoir of the cartridge system in accordance with another embodiment of the present invention;
FIG. 2E illustrates a sectional view of a reservoir of the cartridge system in accordance with yet another embodiment of the present invention;
FIGS. 3A-3C illustrate a perspective view, bottom view and top view, respectively, of a first pump body insert of the cartridge system in accordance with an embodiment of the present invention;
FIGS. 3D-3F illustrate a perspective view, bottom view and top view, respectively, of a second pump body insert of the cartridge system in accordance with an embodiment of the present invention;
FIGS. 4A-4B illustrate a perspective view and front view, respectively, of a pump membrane of the cartridge system in accordance with an embodiment of the present invention;
FIG. 5 illustrates perspective, front and top views of a magnet of the cartridge system in accordance with an embodiment of the present invention;
FIG. 6 illustrates perspective, front and top views of a valve membrane of the cartridge system in accordance with an embodiment of the present invention;
FIGS. 7A-7C illustrate a perspective view, bottom view and top view, respectively, of a first inlet/outlet member of the cartridge system in accordance with an embodiment of the present invention;
FIGS. 7D-7F illustrate a perspective view, bottom view and top view, respectively, of a second inlet/outlet member of the cartridge system in accordance with an embodiment of the present invention;
FIGS. 8A-8C illustrate a perspective view, respectively, of a first housing, a second housing, and a third housing that collectively comprise a reservoir shell of the cartridge system in accordance with an embodiment of the present invention;
FIG. 9A illustrates a perspective view of a cartridge system, and a syringe, in accordance with another embodiment of the present invention;
FIGS. 9B-9C illustrate perspective views of the cartridge system in accordance with another embodiment of the present invention;
FIGS. 10A-10F illustrate a perspective view, front view, rear view, right side view, left side view, and bottom view, respectively, of a drug delivery device comprising a pump driver system and the cartridge system in accordance with an embodiment of the present invention; and
FIG. 11 illustrates the drug delivery device with accessories in accordance with an embodiment of the present invention.
Disclosed embodiments relate to a cartridge system for delivery of medicament and a drug delivery device containing the same.
Referring now to the drawings, where like elements are designated by like reference numerals, FIGS. 1A-1C illustrate a cartridge system 100 in accordance with an embodiment of the invention. The cartridge system 100 includes a plurality of reservoirs 200 a, 200 b, a plurality of pump body inserts 300 a, 300 b, a pump membrane 400, and a plurality of inlet/outlet members 700 a, 700 b.
Basic shape: Shape as shown in FIGS. 8A-8C
Material: RTP 699 × 122676 NS-Acrylonitrile Butadiene
Basic shape: Shape as shown in FIGS. 2A-2C, and made of a
material from a group consisting of elastomer, and the
material having property such that the geometry is
Basic shape: Shape as shown in FIGS. 3A-3F, and having a
Material: Clear polypropylene homopolymer
Basic shape: Shape as shown in FIGS. 7A-7F, and having a fluid
receiving opening, a fluid discharge opening,
plated NdFeB
Basic shape: Shape as shown in FIGS. 4A-4B
Referring to FIGS. 2A-2C, a reservoir 200 a having an opening 203 is shown. The reservoir 200 a is preferably made of elastomers and preferably made by liquid injection molding of Silastic Q7-4840 or transfer molding of Medical Grade Polyisoprene.
The advantages of using polymer materials to make the reservoirs 200 a, 200 b, pump body inserts 300 a, 300 b, inlet/outlet members 700 a, 700 b, and any housing portion is that they can be made in any size, designed in any way and manufactured with biocompatible materials. The polymer reservoirs allow better use of the interior volume available within the pump body, and the collapsible nature of the material allows for more innovative methods for withdrawing the liquid contents. The methods used in the manufacture of the polymer components as well as the arrangement and design of the cartridge system lends itself to being readily adaptable to commonly used sterilization techniques such as gamma irradiation, steam sterilization, or fluidic chemical sterilization.
The reservoir 200 a has a substantially symmetrical body having a top end (not shown), a bottom end (not shown), an inner wall 204, and an outer wall 202. The top end of the reservoir 200 a has an opening 203 that is encircled by the inner wall 204 and the outer wall 202. At the top end, the inner wall 204 and the outer wall 202 project in an upward direction to form a female part 201. The female part 201 is preferably of length about 0.42 inches. The female part 201 is securely engaged to a male part 702 (FIG. 7A) of an inlet/outlet member 700 a (FIG. 7A).
The thickness of the reservoir 200 a is preferably between 50μ and 200μ. The top end, the bottom end, the inner wall 204 and the outer wall 202 enclose a reservoir space for storage of fluid medicament. The reservoirs 200 a, 200 b of the cartridge system 100 are preferably dual reservoir, pre-filled with fluid medicaments, each of the reservoirs 200 a, 200 b capable of holding 1.5 ml of fluid medicament. Although FIGS. 2A-2C illustrate reservoir 200 a, it must be understood that reservoir 200 b is substantially the same.
In another preferred embodiment of the invention, the reservoirs 200 a, 200 b can be any free-form shaped body. The reservoirs 200 a, 200 b can be mounted within a reservoir shell 206, the inside of the reservoir shell 206 having an insulation layer 205.
In yet another preferred embodiment of the invention, as shown in FIG. 2D, the cartridge assembly 100 includes the reservoir 200 a mounted within a reservoir shell 206. The inside of the reservoir shell 206 is provided with an insulation layer 205 that enables temperature control of the fluid medicament within the reservoir 200 a. A cap 207 can be coupled, for example, through molding 208, to the inner wall 204 near the opening 203. The reservoir shell 206 is coupled to the cap 207 and the cap 207 is securely engaged to a male part of the inlet/outlet members 700 a, 700 b (FIGS. 7A-7F).
In yet another preferred embodiment of the invention, as shown in FIG. 2E, the cartridge assembly 100 includes the reservoir 200 a mounted within a reservoir shell 206. The inside of the reservoir shell 206 is provided with an insulation layer 205 that enables temperature control of the fluid medicament within the reservoir 200 a. A cap 207 can be coupled to the inner wall 204 near the opening 203. The reservoir shell 206 is coupled to the cap 207 and the cap 207 is threadedly 209 engaged to a male part of the inlet/outlet members 700 a, 700 b (FIG. 7A-7F).
It is to be understood that the reservoirs 200 a, 200 b mounted within a reservoir shell 206 having an insulation layer 205 or without the reservoir shell 206 can include a cap for removably closing the opening 203. The reservoirs may be designed to work with any drug delivery device for delivery of medicaments.
Referring to FIGS. 3A-3C, a first pump body insert 300 a having a fluid receiving opening 301, and a fluid discharge opening 302 is shown. The first pump body insert 300 a also includes a plurality of output channels 307 a, 307 b, for example, two output channels, and a plurality of input channels 308 a, for example, one input channel. The plurality of output channels 307 a, 307 b and the plurality of input channels 308 a are in fluid communication with the fluid discharge opening 302, and the fluid receiving opening 301, respectively. The plurality of output channels 307 a, 307 b and input channels 308 a are designed to provide membrane support thereby preventing deformation and reverse flow of fluids. The first pump body insert 300 a has an opening 305 to house a magnet 500 (FIG. 5). Apertures 311 a, 311 b, 311 c, 311 d can be used to align and/or secure the first pump body insert 300 a to other elements of the cartridge system 100.
The second pump body insert 300 b, shown in FIGS. 3D-3F, is substantially symmetrical in geometry to the first pump body insert 300 a except having a plurality of output channels 307 a, for example, one output channel, and a plurality of input channels 308 a, 308 b, for example, two input channels. The first pump body insert 300 a and second pump body insert 300 b are preferably made of clear polypropylene homopolymer.
The cartridge system 100 has a pump membrane 400 as shown in FIGS. 4A-4B. The pump membrane 400 is a biocompatible elastomer membrane, preferably made of Silastic Q7-4840. The pump membrane 400 is placed between two disk magnets 500, shown in FIG. 5, which are housed within opening 305 of the first pump body insert 300 a and the second pump body insert 300 b. The disk magnets 500 are preferably gold-plated neodymium-iron-boron grade N42 magnets. The volume of flow of fluid medicaments in the cartridge system 100 is related to the diameter of the magnets 500 and the stroke length. The stroke length can be electromagnetically controlled and monitored by a driver feedback system.
Referring to FIGS. 7A-7C, a first inlet/outlet member 700 a having a fluid receiving opening 704, and a fluid discharge opening 703 is shown. The inlet/outlet member 700 a has a fluid outlet component 701 having a proximal end 701 b, a distal end 701 a and a cylindrical body connecting the distal and the proximal ends to form a hollow for receiving fluid medicament. In one embodiment, the proximal end 701 b can preferably have a tapered end with a luer slip. The inlet/outlet member 700 a includes a male part 702 that securely engages to the female part 201 of the reservoir 200 a. Apertures 705 a, 705 b, 705 c, 705 d can be used to align and/or secure the first inlet/outlet member 700 a to other elements of the cartridge system 100.
The second inlet/outlet member 700 b, shown in FIGS. 7D-7F is substantially symmetrical in geometry to the first pump body insert 700 a. Inlet/outlet members 700 a, 700 b are preferably made of clear polypropylene homopolymer.
The male part 702 of the inlet/outlet members 700 a, 700 b can have tooth-like channels to ensure that a low resistance path for fluid flow exists for all configurations of the reservoirs 200 a, 200 b. The reservoirs 200 a, 200 b, the pump body inserts 300 a, 300 b, the pump membrane 400, and the inlet/outlet members 700 a, 700 b are securely engaged using housing units 800 a, 800 b, 800 c shown in FIGS. 8A-8C.
Four valve membranes 600, shown in FIG. 6, preferably made of Silastic Q7-4840, are placed between (i) the fluid receiving opening 301 of the pump body inserts 300 a, 300 b and the fluid receiving opening 704 of the inlet/out members 700 a, 700 b, and (ii) the fluid discharge opening 302 of the pump body inserts 300 a, 300 b and the fluid discharge opening 703 of the inlet/out members 700 a, 700 b. The introduction of the valve membranes 600 within said openings produce passive, one-way valves which direct fluid flow within the cartridge system 100.
When cartridge system 100 is assembled together, the first reservoir 200 a, the fluid receiving opening 704 of the first inlet/outlet member 700 a, the fluid receiving opening 301 of the first pump body insert 300 a, the plurality of inlet channels 308 a and the plurality of outlet channels 307 a, 307 b of the first pump body insert 300 a, the fluid discharge opening 302 of the first pump body insert 300 a, and the fluid discharge opening 703 and the fluid outlet component 701 of the first inlet/outlet member 700 a are in fluid connection. Likewise, the second reservoir 200 b, the fluid receiving opening 704 of the second inlet/outlet member 700 b, the fluid receiving opening 301 of the second pump body insert 300 b, the plurality of inlet channels 308 a, 308 b and the plurality of outlet channels 307 a of the second pump body insert 300 b, the fluid discharge opening 302 of the second pump body insert 300 b, and the fluid discharge opening 703 and the fluid outlet component 701 of the second inlet/outlet member 700 b are in fluid connection.
In another embodiment of the present invention, a system 900 is shown in FIG. 9A. Referring to FIG. 9A, in the system 900, the medicament can be filled in reservoirs 200 a, 200 b of a cartridge system 101 using an instrument, for example, a syringe 901. Referring to FIGS. 9B-9C, the cartridge system 101 has orifices 902 a, 902 b on the inlet/outlet members 700 a, 700 b which are in fluid connection with reservoirs 200 a, 200 b, respectively. Alternatively, the orifices 902 a, 902 b can be located on the reservoirs 200 a, 200 b.
Referring to FIGS. 10A-10D, a drug delivery device 1000 including a pump driver system 1001 and the cartridge system 100 is shown. The cartridge system 100 snaps into the pump driver system 1001 and is securely engaged to it. The pump driver system 1001 includes, among others, a driver, a controller, and a power source. The driver electromagnetically drives the magnets 500 that applies a force to the pump membrane 400 causing it to deflect resulting in precise volumetric delivery of the fluid medicament from the reservoirs 200 a, 200 b. The deflection of the pump membrane 400 results in a change of pressure within the chambers of the reservoirs 200 a, 200 b resulting in an outward flow of the fluid medicament contained within the reservoirs 200 a, 200 b. The force applied by the driver onto the pump membrane 400 can be adjusted using the controller. The drug delivery device 1000 can be powered by batteries, connected to a power outlet using an adapter, or other sources of power.
Referring to FIG. 11, the drug delivery device 1000 with accessories 1101, 1102 is shown. A conduit 1101 for delivering the fluid medicament from the drug delivery 1000 is preferably, a single tube catheter or a Y-catheter. The distal end of the conduit 1101 is securely attached to a luer slip on the proximal end 701 b of the fluid outlet component 701 of the inlet/outlet member 700 a in the cartridge system 100. The proximal end of the conduit 1101 is securely engaged to a cannula and insertion mechanism 1102 including a sensor and a needle. When the drug delivery device 1000 uses two reservoirs 200 a, 200 b, the conduit is preferably a duel tube Y-catheter whose distal ends are securely attached to the luer slips on the proximal ends 701 b of the fluid outlet component 701 of the inlet/outlet members 700 a, 700 b. The proximal end of the conduit 1101 is securely engaged to a cannula and insertion mechanism 1102 including a sensor and a needle whereby the two medicaments are mixed in the canola before entering the needle. In another method of delivering the medicament, the cannula and insertion mechanism 1102 has a plurality of needles and the medicaments are delivered through separate needles.
A diabetic patient can use the drug delivery device 1000 along with the accessories 1101, 1102 shown in FIG. 11. In a method of delivering medicament using a drug delivery device 1000, a drug delivery device 1000 having a pump driver system 1001 and a cartridge system 100 is provided to the patient user. A plurality of pre-filled reservoirs 200 a, 200 b containing fluid medicaments are loaded to the cartridge system 100. The cartridge system 100 is then snapped into and securely engaged to the pump driver system 1001. The user then selects various parameters on a user interface on the pump driver system 1001. These parameters can include, but not be limited to, basal rate, insulin amount, bolus rate based on the calories of carbohydrates, protein, fat or fiber consumed, and the blood glucose level including the actual and target glucose levels. The user can either select pre-determined values or specify user-defined values for each of the parameters. The user connects an infusion set having accessories 1101, 1102 to the drug delivery device 1000.
The step of connecting an infusion set to the drug delivery device can include connecting the distal ends of a Y-catheter to the luer slips of the fluid outlet component of the inlet/outlet members. Subsequently, the patient user can place an inset of the infusion set on a body part of the patient, attach the infusion set to the body, and switch on the drug delivery device. When the patient user uses only one reservoir in the cartridge system, the step of connecting an infusion set to the drug delivery device can include connecting the distal end of the Y-catheter to the luer slip of the outlet component of the inlet/outlet member.
In another method of delivering medicament using the drug delivery device 1000 having the cartridge system 100, a drug delivery device 1000 having a pump driver system 1001 and a cartridge system 100 is provided to the patient user. A plurality of reservoirs 200 a, 200 b are loaded to the cartridge system 100 and the reservoirs 200 a, 200 b are filled with medicaments using an instruments, for example, a syringe. The cartridge system 100 is then snapped into and securely engaged to the pump driver system 1001. The user then selects various parameters on a user interface on the pump driver system 1001. These parameters can include, but not be limited to, basal rate, insulin amount, bolus rate based on the calories of carbohydrates, protein, fat or fiber consumed, and the blood glucose level including the actual and target glucose levels. The user can either select pre-determined values or specify user-defined values for each of the parameters. The user connects an infusion set having accessories 1101, 1102 to the drug delivery device 1000. Subsequently, the patient user can place an inset of the infusion set on a body part of the patient, attach the infusion set to the body, and switch on the drug delivery device.
a first reservoir and a second reservoir, wherein the first reservoir and the second reservoir each include a body having: a top end, a bottom end, an inner wall, and an outer wall enclosing a reservoir space; an opening formed in the top end, the opening being encircled by the outer wall and the inner wall, and the outer and inner walls projecting upwardly at the top end to form a female portion;
a first inlet/outlet member having a male portion configured to engage the female portion of the first reservoir, the first inlet/outlet member having a fluid receiving opening, a fluid discharge opening, and a fluid outlet component, the fluid receiving opening of the first inlet/outlet member in fluid communication with the first reservoir, and the fluid outlet component of the first inlet/outlet member in fluid communication with the fluid discharge opening of the first inlet/outlet member;
a second inlet/outlet member having a male portion configured to engage the female portion of the second reservoir, the second inlet/outlet member having a fluid receiving opening, a fluid discharge opening, and a fluid outlet component, the fluid receiving opening of the second inlet/outlet member in fluid communication with the second reservoir, and the fluid outlet component of the second inlet/outlet member in fluid communication with the fluid discharge opening of the second inlet/outlet member;
a first pump body insert having a fluid receiving opening, a fluid discharge opening, a plurality of inlet channels, and a plurality of outlet channels, the fluid receiving opening of the first pump body insert in fluid communication with the plurality of inlet channels of the first pump body insert, the plurality of inlet channels of the first pump body insert in fluid communication with the plurality of outlet channels of the first body insert, and the plurality of outlet channels of the first pump body insert in fluid communication with the fluid discharge opening of the first pump body insert;
a plurality of magnets, at least one of the plurality of magnets having a distal end, a proximal end, and a body extending between the distal and proximal ends, and the proximal end being in contact with the pump membrane and the distal end being housed within at least one of the first and second pump body inserts,
2. The cartridge system of claim 1, further comprising:
a plurality of valve membranes, wherein at least one of the valve membranes is located between the fluid receiving opening of the first pump body insert and the first inlet/outlet member, at least one, of the valve membranes is located between the fluid receiving opening of the second pump body insert and the second inlet/outlet member, at least one of the valve membranes is located between the fluid discharge opening of the first pump body insert and the first inlet/outlet member, and at least one of the valve membranes is located between the fluid discharge opening of the second pump body insert and the second inlet/outlet member.
3. The cartridge system of claim 1, wherein the fluid outlet component of the first inlet/outlet member and the fluid outlet component of the second inlet/outlet member each has a distal end, a proximal end, and a cylindrical body connecting the respective distal and the proximal ends, wherein the proximal end of the fluid outlet component of the first inlet/outlet member is in fluid communication with the fluid discharge opening of the first inlet/outlet member, and wherein the proximal end of the fluid outlet component of the second inlet/outlet member is in fluid communication with the fluid discharge of the second inlet/outlet member.
4. The cartridge system of claim 1, further comprising:
a plurality of reservoir shells; and
an insulation layer provided within at least one of the plurality of reservoir shells, wherein the first reservoir and the second reservoir are each mounted within a said reservoir shell.
5. The cartridge system of claim 4, further comprising a cap, wherein the cap is coupled to the inner wall of the first reservoir and secures the first reservoir to the male portion of the first inlet/outlet member.
6. The cartridge system of claim 4, further comprising a cap, wherein the cap is coupled to the inner wall of the first reservoir, and the cap and the first reservoir are contained within at least one shell.
7. The cartridge system of claim 4, further comprising a cap, wherein the cap is coupled to the inner wall of the second reservoir and secures the second reservoir to the male portion of the second inlet/outlet member.
8. The cartridge system of claim 4, further comprising a cap, wherein the cap is coupled to the inner wall of the second reservoir near the male portion of the second inlet/outlet member.
9. The cartridge system of claim 4, wherein the first reservoir and the second reservoir are mounted within the same reservoir shell.
10. The cartridge system of claim 4, wherein the first reservoir and the second reservoir are mounted within different reservoir shells.
11. The cartridge system of claim 1, wherein the first and the second reservoir are located within a housing unit.
12. The cartridge system of claim 11, wherein the housing unit is made of Acrylonitrile Butadiene Styrene Medical Grade.
13. The cartridge system of claim 1, wherein the first reservoir contains a first fluid medicament and the second reservoir contains a second fluid medicament.
14. The cartridge system of claim 13, wherein the first reservoir and the second reservoir are pre-filled with the first fluid medicament and the second fluid medicament, respectively.
15. The cartridge system of claim 13, wherein the first fluid medicament includes insulin and the second fluid medicament includes glucagon.
16. The cartridge system of claim 1, wherein the pump membrane is prestressed and is made of silicone.
17. The cartridge system of claim 1, wherein the plurality of magnets are made of gold-plated neodymium-iron-boron.
18. The cartridge system of claim 1, wherein the first and second reservoirs are made of at least one material from the group consisting of silicone and Medical Grade Polyisoprene.
19. The cartridge system of claim 1, further comprising an orifice located on at least one of the first inlet/outlet member and the second inlet/outlet member.
US13308899 2011-12-01 2011-12-01 Cartridge system for delivery of medicament Active 2031-12-20 US8771229B2 (en)
EP20120809886 EP2785394A1 (en) 2011-12-01 2012-11-29 Cartridge system for delivery of medicament
PCT/US2012/066937 WO2013082209A1 (en) 2011-12-01 2012-11-29 Cartridge system for delivery of medicament
US14288052 US9993592B2 (en) 2011-12-01 2014-05-27 Cartridge system for delivery of medicament
US13370091 Continuation-In-Part US8790307B2 (en) 2011-12-01 2012-02-09 Drug delivery device and methods therefor
US14288052 Continuation US9993592B2 (en) 2011-12-01 2014-05-27 Cartridge system for delivery of medicament
US20130144214A1 true US20130144214A1 (en) 2013-06-06
US8771229B2 true US8771229B2 (en) 2014-07-08
ID=47501416
US13308899 Active 2031-12-20 US8771229B2 (en) 2011-12-01 2011-12-01 Cartridge system for delivery of medicament
US14288052 Active US9993592B2 (en) 2011-12-01 2014-05-27 Cartridge system for delivery of medicament
US (2) US8771229B2 (en)
EP (1) EP2785394A1 (en)
WO (1) WO2013082209A1 (en)
US20130237947A1 (en) * 2012-03-09 2013-09-12 Farid Amirouche Multi-ported drug delivery device having multi-reservoir cartridge system
JPH0544331B2 (en) 1986-06-18 1993-07-06 Hoya Corp
US7061108B2 (en) 2003-10-02 2006-06-13 Texas Instruments Incorporated Semiconductor device and a method for securing the device in a carrier tape
US8771229B2 (en) * 2011-12-01 2014-07-08 Picolife Technologies, Llc Cartridge system for delivery of medicament
"Diabetic Neurpathy, Living With Numbness and Pain," A Diabetic Life, [Online]. Available at: http://www.a-diabetic-life.com/diabetic-neurpathy.html [Accessed May 5, 2012] (3 pages).
"Electromyogram (EMG)," MedicineNet.com, [Online]. Available at: http://www.medicinenet.com/electromyogram/article.htm [Accessed May 15, 2012] (3 pages).
"Nerve conduction velocity,"Medline Plus®, A Service of the U.S. National Library of Medicine, National Institutes of Health [Online], Available at: http://www.nlm/nih.gov/medlineplus/ency/article/003927.htm; updated Jun. 18, 2011 (3 pages).
"Peripheral Neuropathy Market Approaches US$1B by 2012," PR Newswire, United Business Media [Online]. Available at: http://www.prnewswire.co.uk/new-releases/peripheral-neuropathymarket-approaches-us1b-by-2012-154534705.html, Apr. 7, 2012 (2 pages).
"Silastic © Biomedical Grade Liquid Silicone Rubbers", Dow Corning, 2006, accessed at http://www4.dowcorning.com/DataFiles/09007c680097196.pdf (6 pages).
"Silastic® Biomedical Grade ETR elastomers", Dow Corning, 2002-2011, accessed at http://www4.dowcorning.com/DataFiles/09007c8802869a.pdf (5 pages).
"Small, powerful, light precise: micro diaphragm pumps made of plastics: thinXXS micropumps" Mar. 2009, [online] http://www.thinxxs. com/main/produkte.micropumps.html (2 pages).
Acevedo, "Creation of Dual Chamber Micropump Using Rapid Prototyping," Milwaukee School of Engineering, Research Experience for Undergraduates Paper, 2005, Available online at: http://www.msoe.edu/academics/research-centers/reu/pdf/2005/Creation%20of%20a%20Dual%20Chamber%20Micropump%20using%20Rapid%20Prototyping.pdf (6 pages).
Acevedo, "Creation of Dual Chamber Micropump Using Rapid Prototyping," Milwaukee School of Engineering, Research Experience for Undergraduates Paper, 2005, Available online at: http://www.msoe.edu/academics/research—centers/reu/pdf/2005/Creation%20of%20a%20Dual%20Chamber%20Micropump%20using%20Rapid%20Prototyping.pdf (6 pages).
Amirouche et al., "Current Micropump Technologies and Their Biomedical Applications,"Microsystem Technolohgy, 2009, pp. 647-666, vol. 15.
Barbano et al., "Effectiveness, Tolerability and Impact on Quality of Life of the 5% Lidocaine Patch in Diabetic Polyneuropathy," Archives of Neurology, 2004, pp. 914-918, vol. 61, No. 6.
Casella et al., "Accuracy and Precision of Low-Dose Insulin Administration," Pediactrics, 1993, pp. 1155-1157, vol. 91.
Dario et al., "A fluid handling system for chemical microanalyzer," J. Micromech Microeng., vol. 6, pp. 95-98, 1996.
Einhorn et al., "Advances in Diabetes for the Millennium: Insulin Treatment and Glucose Monitoring," Medscope General Medicine, 2004, p. 8, vol. 6, (3 Suppl.) [Online], Available at: http://www.medscope.org/viewarticle/48996 (9 pages).
Elleri et al., "Closed-Loop Insulin Delivery for Treatment of Type 1 Diabetes," BMC Medical, 2011, p. 120, vol. 9, [Online]. Available at: http://www.biomedcentral.com/1741-7015/9/120 (9 pages).
Farnbach, "Peripheral Nerve Testing and Electromyography," [Online]. Available at: http://www.cal.vet.upenn.edu/projects/saorthor/appendix-d/appd.htm. [Accessed May 18, 2012]. (10 pages).
Farnbach, "Peripheral Nerve Testing and Electromyography," [Online]. Available at: http://www.cal.vet.upenn.edu/projects/saorthor/appendix—d/appd.htm. [Accessed May 18, 2012]. (10 pages).
Fu et al., "TiNi-Based thin films in MEMS applicant: a rewiew," Sensors and Acutators A, 2004, pp. 395-408, vol. 112, No. 23.
Galer et al., "The Lidocaine Patch 5% Effectively Treats all Neuropathic Pain Qualities: Results of a Randomized. Double-Blind, Vehicle-Controlled, 3-Week Efficacy Study with Use of the Neuropathic Pain Scale," The Clinical Journal of Pain, 2002, pp. 297-301, vol. 18, No. 5 (Abstract).
Gammaitoni et al., "Pharmacokinetics and Tolerability of Lidocaine Patch 5% with Extended Dosing," The Annals of Pharmacotherapy, 2002, pp. 236-240, vol. 36, No. 2. (Abstract).
International Search Report and Written Opinion issued in PCT International Application No. PCT/US2012/066937, mailed Mar. 7, 2013 (9 pages total).
Koch, et al., "PDMS and tubing-based peristaltic micropumps with direct education," Sensors and Acutators B, vol. 135, pp. 654-670, 2009.
Laser et al., "A review of rnicropumps," J. Micromech. Microeng., vol. 14(6), pp. R35-R64, 2004.
Lee et al., "Microfluidic mixing: A review," Int. J. Mol. Sci., 2011, pp. 3283-3287, vol. 12.
Li et al., "A high frequency high flow rate piezoelectrically driven MEMS micropump" in Proceedings IEEE Solid State Sensors and Actuators Workshop, Hilton Head, SC, Jun. 2000 (4 pages)
Meece et al., "Effect of insulin Pen Devices on the Management of Diabetes Mellitus," Am J Health-Syst. Pharm., 2008, pp. 1078-1082, vol. 65.
Melin et al, "A fast passive and planar liquid sample micromixer," Lab on a Chip, 2004, pp. 214-219, vol. 4.
Morrow, "Transdermal Patches Are More Than Skin Deep," Managed Care [Online]. Available at: http.//www.managedcaremag.com/archives/0404/0404.biotech.html. Apr. 2004 (4 pages).
Mundell, "Antidepressant Cymbalta Might Ease Chemo-Linked Pain," MSN Healthy Living, 2013 [Online]. Available at: http://health.msn.com/health-topics/cancer/antidepressant-cynmbalta-might-ease-chemo-linked-pain (4 pages).
Nguyen et al, "Microfluidics for Internal Flow Control: Micropumps," in Fundamentals and Applications of Microfluidics. Norwood, MA: Artech House, Inc., 2002; pp. 293-341.
Nguyen et al., "MEMS-micropumps. A review," Journal of Fluids Engineering, vol. 124, p. 384-392, 2002.
Pan at al, "A magnetically driven PDMS micropump with bail check-valves," J. Micromech. Microeng, vol. 15, pp. 1021-1026, 2005.
Rapp at al., "Liga micropump for gases and liquids," Sensors and Actuators A, 1994, pp. 57-61, vol. 40, No. 1.
Richardson at al., "Peripheral Neuropathy: A True Risk Factor for Falls," The Journal of Gerontology: Series A, 1995, pp. 211-215, vol. 50, No. 4 (Abstract).
Selam "Evolution of Diabetes Insulin Delivery Devices," Journal of Diabetes Science and Technology, 2010, pp. 505-513, vol. 4. No. 3.
Shen at al., "Miniaturized PMMA ball-valve micropump with cylindrical electromagnetic actuator," Microelectronic Erigineering, vol. 85, pp. 1104-1107, 2008.
Star Micronics Co. Ltd., "Precision products," Mar. 2009, [online] Accessed at: http://www.star-m.jp/eng/products/precision/index/html, on Aug. 22, 2011 (4 pages).
U.S. Appl. No. 13/174,624, filed Jun. 30, 2011 by Amirouche et al., Final Rejection, dated Nov. 21, 2012.
U.S. Appl. No. 13/174,643, filed Jun. 30, 2011 by Amirouche et al.: Notice of Aliowance, dated Oct. 21, 2013.
Yamahata, et al. "A PMMA valveless micropump using electromagnetic actuation," Microfluid Nanofluid. vol. 1, pp. 197-207, 2005.
Zhu et al., "Optimization design of multi-material micropump using finite element method" Sensors and Actuators A, vol. 149, pp. 130-135, 2009.
US9993592B2 (en) * 2011-12-01 2018-06-12 Picolife Technologies, Llc Cartridge system for delivery of medicament
US9993592B2 (en) 2018-06-12 grant
EP2785394A1 (en) 2014-10-08 application
US20140257350A1 (en) 2014-09-11 application
WO2013082209A1 (en) 2013-06-06 application
US20130144214A1 (en) 2013-06-06 application
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AMIROUCHE, FARID;ATTAR, ARASH N;CANTWELL, MATTHEW L;REEL/FRAME:027664/0692